Methylenedioxyethylamphetamine

Methylenedioxyethylamphetamine

Methylenedioxyethylamphetamine
Systematic (IUPAC) name
1-(1,3-Benzodioxol-5-yl)-N-ethyl-propan-2-amine
Clinical data
Legal status
  • Schedule I (US)
Identifiers
CAS number
ATC code ?
PubChem
ChemSpider
Chemical data
Formula C12H17NO2 
Mol. mass 207.27 g/mol

Methylenedioxyethylamphetamine (3,4-methylenedioxy-N-ethylamphetamine; MDEA; MDE, "Eve") is a psychedelic and entactogenic drug of the phenethylamine and amphetamine chemical classes.

Like 3,4-methylenedioxyamphetamine (MDA), MDEA acts as a serotonin, norepinephrine, and dopamine releasing agent.[1][2][3]

The subjective effects of MDEA are very similar to those of methylenedioxymethamphetamine (MDMA). However, the euphoric and "loved up" feelings associated with MDMA are not as pronounced in comparison. It is said to be stoning in high doses.[3]

See also

References

  1. ^ Freudenmann RW, Spitzer M (2004). "The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA)". CNS Drug Reviews 10 (2): 89–116.  
  2. ^ Subjective Differences Between MDE and MDMA
  3. ^ a b Erowid Online Books : "PiHKAL" - #106 MDE

External links

  • Erowid MDE Vault
  • MDE entry in PiHKAL